The importance of non-transferrin bound iron in disorders of iron metabolism
Top Cited Papers
- 28 November 2000
- journal article
- review article
- Published by Elsevier in Transfusion Science
- Vol. 23 (3), 185-192
- https://doi.org/10.1016/s0955-3886(00)00087-4
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Desferrioxamine-chelatable iron (DCI), a component of serum non-transferrin-bound iron (NTBI) used for assessing iron chelation therapyTransfusion Science, 2000
- A Novel Duodenal Iron-Regulated Transporter, IREG1, Implicated in the Basolateral Transfer of Iron to the CirculationMolecular Cell, 2000
- Discovery of the Ceruloplasmin Homologue Hephaestin: New Insight into the Copper/Iron ConnectionNutrition Reviews, 2000
- Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron effluxProceedings of the National Academy of Sciences, 1999
- Interaction of serum albumin with the Fe(III)-citrate complexInternational Journal of Biochemistry, 1993
- Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosisJournal of Biological Chemistry, 1989
- Nontransferrin-bound iron in plasma from hemochromatosis patients: effect of phlebotomy therapyBlood, 1988
- A non-transferrin-bound serum iron in idiopathic hemochromatosisDigestive Diseases and Sciences, 1980
- Nonspecific serum iron in thalassemia: Quantitation and chemical reactivityAmerican Journal of Hematology, 1979
- Non‐Specific Serum Iron in Thalassaemia: an Abnormal Serum Iron Fraction of Potential ToxicityBritish Journal of Haematology, 1978